Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is st...

• Country None
• organs None
• Specialty None

Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Aldesleukin may stimulate the white blood cells to kill breast cancer cells. Giving vaccine th...

• Country None
• organs None
• Specialty None

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer RATIONALE: Estrogen can cause the growth of breast cancer cells. Naltrexone may fight breast cancer by blocking the use of estrogen by the tumor cells. Naltrexone may also stop the growth ...

• Country None
• organs None
• Specialty None

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery RATIONALE: Monoclonal antibodies, such as CP-751871, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help ki...

• Country None
• organs None
• Specialty None